Navigation Links
Industry Advisor Joins OrthoAccel Technologies, Inc.

HOUSTON, Jan. 25 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced this week that it has engaged Waldemar "Val" B. Szwajkowski as an advisor and consultant.  Mr. Szwajkowski's relationship with the Company will be primarily focused on strategic development of key markets, and alignment of its operating plans for growth.


AcceleDent is a simple, removable dental device that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement.  A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety of the device.  The first case in private practice was initiated in October 2009 in the UK, following EU approval.  

Mr. Szwajkowski's background is particularly relevant to OrthoAccel's development of the AcceleDent brand.  His extensive experience includes international business development, sales and marketing, and general management.  While at 3M Unitek, an orthodontic appliance business, his roles included market leadership in Latin American and Europe from the 1980s into the early 2000s.  Mr. Szwajkowski also oversaw several acquisitions and new business launches prior to retiring as Global Head of 3M Unitek, a role he held from 2001 – 2007.  

Michael Lowe, CEO of OrthoAccel, commented, "We are committed to building the AcceleDent brand around the customer above all else and we believe that Val can provide critical insight to help us guide the development of this new product category.  The management team here is very pleased to have his consultation and involvement in what we are doing."  Mr. Szwajkowski remarked, "I look forward to working with OrthoAccel's strong, talented team in bringing a highly innovative product applying leading edge, clinically proven biomedical bone stimulation techniques into the orthodontic market."

Last month, OrthoAccel hired a Director of Sales in the United Kingdom, which is where efforts will be focused in 2010, as well as in Australia.  Canada is also a planned market for this year, although regulatory clearance is pending.  

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling.  Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at or requested via

Media Contact  Michael K. Lowe, CEO, +1 (832) 631-1659

SOURCE OrthoAccel Technologies, Inc.



SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
4. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
5. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
6. Health Insurance Industry Contributions to Politicians Block Regulation, Affordability in Health Care Debate, Says FTCR
7. UNH, state health agency, private industry and NASA to tackle Lyme disease
8. System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs
9. Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System
10. AT&T Offers Network Industry-First RFID Solution for Health Care Organizations
11. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
(Date:11/27/2015)... San Francisco, California (PRWEB) , ... November 27, 2015 , ... ... 1969 Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of ... 1969 at the Canterbury House at the University of Michigan in Ann Arbor. The ...
(Date:11/26/2015)... ... 2015 , ... Patients at Serenity Point Recovery, a holistic ... Thanksgiving Day to share the things that they are most grateful for today. ... channel, patients displayed what they wrote on index cards, describing the things that ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge ... imaging in the Waterloo region. Using the Ocean Platform, family physicians can now ... their electronic medical record (EMR) without the need for redundant patient entry or ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Research and Markets ( ) has announced the addition ... 2019 - Rise in Cardiac Disorders and Growing Awareness among ... offering. Boston scientific and ... and others. --> The market is dominated ... scientific and others. Asia ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Japanese therapeutic drug monitoring market, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: